| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ULUFA
|
1.65 | 891.0M | 1.19 | 0.44 | 2.06 | — | — | 76 | 51 | 4.09 | +110.9% | 66 | 7.12 |
|
LIDFA
|
2.59 | 2.8B | 2.73 | 0.89 | — | — | — | 73 | 29 | 4.98 | +59.1% | 67 | 3.64 |
|
GARFA
|
26.88 | 10.7B | 4.45 | 1.79 | — | — | — | 70 | 34 | 37.24 | +24.7% | 66 | 5.83 |
|
CRDFA
|
27.00 | 24.3B | 100.00 | 40.81 | 127.49 | — | — | 34 | 8 | 6.86 | -56.0% | 74 | 2.15 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.